Does EMPAGLIFLOZIN Cause Injection site warmth? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Injection site warmth have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.1% of all adverse event reports for EMPAGLIFLOZIN.
27
Reports of Injection site warmth with EMPAGLIFLOZIN
0.1%
of all EMPAGLIFLOZIN reports
0
Deaths
26
Hospitalizations
How Dangerous Is Injection site warmth From EMPAGLIFLOZIN?
Of the 27 reports, 26 (96.3%) required hospitalization.
Is Injection site warmth Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,644)
Fungal infection (1,941)
Blood glucose increased (1,797)
Euglycaemic diabetic ketoacidosis (1,769)
Weight decreased (1,661)
Urinary tract infection (1,439)
Ketoacidosis (1,411)
Dizziness (1,372)
Nausea (1,333)
Vomiting (1,201)
What Other Drugs Cause Injection site warmth?
ETANERCEPT (4,011)
ADALIMUMAB (1,275)
DUPILUMAB (889)
ENBREL (544)
IXEKIZUMAB (480)
GLATIRAMER (372)
HYDROXYPROGESTERONE CAPROATE (287)
HUMIRA (261)
NALTREXONE (231)
TIRZEPATIDE (213)
Which EMPAGLIFLOZIN Alternatives Have Lower Injection site warmth Risk?
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN vs EMSAM
EMPAGLIFLOZIN vs EMTRICITABINE